About lab
One published Lab
Build with this Lab. Run it anywhere.
Use the same immutable release locally or through managed cloud execution, with its exact version and provenance preserved.
Preparing exact examples…
The paper describes a model of antitumor vaccine therapy.Created by COPASI 4.25 (Build 207) This model is described in the article: A Mathematical Model of the Enhancement of Tumor Vaccine Efficacy by. It can be used to explore immune response dynamics and compare pathway-level behavior across conditions.
Manifest
{
"io": {
"inputs": [
{
"name": "initial_unresolved_tumor_observable_1",
"label": "Initial Unresolved Tumor Observable 1",
"units": "substance",
"default": 3,
"maps_to": "immunology_sbml_wilson2012_tumor_vaccine_efficacy_biomd0000000791_model.initial_unresolved_tumor_observable_1",
"description": "Initial Unresolved Tumor Observable 1. Sets the initial value of bundled SBML species `T`."
},
{
"name": "initial_unresolved_tumor_observable_2",
"label": "Initial Unresolved Tumor Observable 2",
"units": "substance",
"default": 0,
"maps_to": "immunology_sbml_wilson2012_tumor_vaccine_efficacy_biomd0000000791_model.initial_unresolved_tumor_observable_2",
"description": "Initial Unresolved Tumor Observable 2. Sets the initial value of bundled SBML species `B`."
},
{
"name": "initial_unresolved_tumor_observable_3",
"label": "Initial Unresolved Tumor Observable 3",
"units": "substance",
"default": 100,
"maps_to": "immunology_sbml_wilson2012_tumor_vaccine_efficacy_biomd0000000791_model.initial_unresolved_tumor_observable_3",
"description": "Initial Unresolved Tumor Observable 3. Sets the initial value of bundled SBML species `E`."
},
{
"name": "initial_unresolved_tumor_observable_4",
"label": "Initial Unresolved Tumor Observable 4",
"units": "substance",
"default": 1,
"maps_to": "immunology_sbml_wilson2012_tumor_vaccine_efficacy_biomd0000000791_model.initial_unresolved_tumor_observable_4",
"description": "Initial Unresolved Tumor Observable 4. Sets the initial value of bundled SBML species `R`."
},
{
"name": "initial_unresolved_tumor_observable_5",
"label": "Initial Unresolved Tumor Observable 5",
"units": "substance",
"default": 0,
"maps_to": "immunology_sbml_wilson2012_tumor_vaccine_efficacy_biomd0000000791_model.initial_unresolved_tumor_observable_5",
"description": "Initial Unresolved Tumor Observable 5. Sets the initial value of bundled SBML species `V`."
},
{
"name": "tgfb_decay_rate",
"label": "Tgfb Decay Rate",
"units": "unit_1",
"default": 0.0007,
"maps_to": "immunology_sbml_wilson2012_tumor_vaccine_efficacy_biomd0000000791_model.tgfb_decay_rate",
"description": "Tgfb Decay Rate. Sets bundled SBML parameter `d`."
}
],
"outputs": [
{
"name": "unresolved_tumor_observable_1",
"maps_to": "immunology_sbml_wilson2012_tumor_vaccine_efficacy_biomd0000000791_model.unresolved_tumor_observable_1"
},
{
"name": "unresolved_tumor_observable_2",
"maps_to": "immunology_sbml_wilson2012_tumor_vaccine_efficacy_biomd0000000791_model.unresolved_tumor_observable_2"
},
{
"name": "unresolved_tumor_observable_3",
"maps_to": "immunology_sbml_wilson2012_tumor_vaccine_efficacy_biomd0000000791_model.unresolved_tumor_observable_3"
},
{
"name": "unresolved_tumor_observable_4",
"maps_to": "immunology_sbml_wilson2012_tumor_vaccine_efficacy_biomd0000000791_model.unresolved_tumor_observable_4"
},
{
"name": "unresolved_tumor_observable_5",
"maps_to": "immunology_sbml_wilson2012_tumor_vaccine_efficacy_biomd0000000791_model.unresolved_tumor_observable_5"
},
{
"name": "state",
"maps_to": "immunology_sbml_wilson2012_tumor_vaccine_efficacy_biomd0000000791_model.state"
},
{
"name": "summary",
"maps_to": "immunology_sbml_wilson2012_tumor_vaccine_efficacy_biomd0000000791_model.summary"
},
{
"name": "species_labels",
"maps_to": "immunology_sbml_wilson2012_tumor_vaccine_efficacy_biomd0000000791_model.species_labels"
}
]
},
"title": "Wilson2012 - tumor vaccine efficacy Lab",
"models": [
{
"path": "models/core",
"alias": "immunology_sbml_wilson2012_tumor_vaccine_efficacy_biomd0000000791_model"
},
{
"path": "models/visualisation",
"alias": "visualisation"
}
],
"wiring": [
{
"to": [
"visualisation.immunology_sbml_wilson2012_tumor_vaccine_efficacy_biomd0000000791_model_state"
],
"from": "immunology_sbml_wilson2012_tumor_vaccine_efficacy_biomd0000000791_model.state"
},
{
"to": [
"visualisation.immunology_sbml_wilson2012_tumor_vaccine_efficacy_biomd0000000791_model_summary"
],
"from": "immunology_sbml_wilson2012_tumor_vaccine_efficacy_biomd0000000791_model.summary"
},
{
"to": [
"visualisation.immunology_sbml_wilson2012_tumor_vaccine_efficacy_biomd0000000791_model_species_labels"
],
"from": "immunology_sbml_wilson2012_tumor_vaccine_efficacy_biomd0000000791_model.species_labels"
}
],
"package": "wilson2012-tumor-vaccine-efficacy",
"runtime": {
"duration": 10,
"initial_inputs": {},
"communication_step": 1
},
"version": "1.0.0",
"description": "The paper describes a model of antitumor vaccine therapy.Created by COPASI 4.25 (Build 207) This model is described in the article: A Mathematical Model of the Enhancement of Tumor Vaccine Efficacy by. It can be used to explore immune response dynamics and compare pathway-level behavior across conditions.",
"schema_version": "2.0"
}Runtime
Duration10
Comms Step1
Runs
Total0
Completed0
Failed0
Metadata
Packagewilson2012-tumor-vaccine-efficacy
Created2026-05-15
Updated2026-06-13
immunologysbmlbiomodels_ebifaithfulcuratedvisualisationother